Ivy Gardner, MD
Colon & Rectal Surgery · Sacramento, CANPI 1972967008
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (41.3%), education and grants — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 45.0% of the total. Reporting peaked in 2023 at $2,741 and has fallen 59.8% since, to $1,103 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in CA, where the typical reported total is $3,373.
Across 35 payments — averaging $113.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Intuitive Surgical$1K
- Cook Incorporated$777
- Boston Scientific$142
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$105
- Braintree Laboratories, Inc.$83
- plus $53 from 3 others
What the payments were for
- Grants$77720%
- Travel & lodging$1,64441%
- Food & beverage$56314%
- Education$1,00025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $1,794 |
| Intuitive Surgical | 2 | $1,029 |
| Cook Incorporated | 1 | $777 |
| Boston Scientific | 1 | $142 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $105 |
| Braintree Laboratories, Inc. | 4 | $83 |
| Ardelyx, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$1,376
- DAVINCI XI$1,000
How this compares
$3,984 in reported general payments places this provider in the 50th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 100 | $6,225 |
| Oxycodone Hcl | 34 | $144 |
| Neomycin Sulfate | 29 | $63 |
| Hydrocortisone | 13 | $52 |
| Metronidazole | 32 | $46 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Sacramento
- Elizabeth RaskinSacramento$126K
- Ankit SarinSacramento$60K
- Erik NorenSacramento$25K
- Sang LeeLos Angeles$2.4M
- Pamela LeeSan Diego$544K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
- Joseph CarmichaelOrange$99K
- Phillip FleshnerWest Hollywood$95K
- Zuri MurrellBeverly Hills$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.